The binding interactions of Ro 40-5967 at the L-type Ca2+ channel in cardiac tissue-Reference-Cited by-同舟云学术

The binding interactions of Ro 40-5967 at the L-type Ca2+ channel in cardiac tissue

Published:1995-07 Issue:2 Volume:280 Page:155-158
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Rutledge Aleta,Triggle David J.

Publisher

Elsevier BV

Subject

Pharmacology

Reference24 articles.

1. The relationship between the binding site of [3H]-d-cis diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma;Balwierczak;Mol. Pharmacol.,1987

2. Ca2+ channel actions of the non-dihydropyridine Ca2+ channel antagonist Ro 40-5967 in vascular muscle cells cultured from dog coronary and saphenous arteries;Bain;Naunyn-Schmied. Arch. Pharmacol.,1993

3. Nitrendipine block of cardiac calcium channels: high affinity binding to the inactivated state;Bean,1984

4. Characterization of binding of the Ca2+ channel antagonist, [3H]nitrendipine, to guinea pig ileal smooth muscle;Bolger;J. Pharmacol. Exp. Ther.,1983

5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding;Bradford;Anal. Biochem.,1976

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calcium Uptake Inhibition Activity;Drug Discovery and Evaluation: Pharmacological Assays;2016

2. Calcium Uptake Inhibition Activity;Drug Discovery and Evaluation: Pharmacological Assays;2015

3. The L-Type Ca2+ Channel as a Therapeutic Target in Heart Disease;Current Medicinal Chemistry;2009-09-01

4. The Mibefradil Derivative NNC55-0396, a Specific T-Type Calcium Channel Antagonist, Exhibits Less CYP3A4 Inhibition than Mibefradil;Drug Metabolism and Disposition;2008-04-14

5. Cardiovascular Activity;Drug Discovery and Evaluation;2007